Analystreport

Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Citigroup Inc. from $27.00 to $16.00.

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations